Cancer Family
Melanocytic Neoplasm
CI-CAN-00000026Explore in graph →
Non-malignant610 active trials13 approved drugs233 evidence items
- NCIt
- C7058
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000026Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02508909 | Videoscopic Ilioinguinal Lymphadenectomy for Melanoma | completed | N/A | 23 | Istituto Oncologico Veneto IRCCSOTHER | 0 | Jul 27, 2015 | clinicaltrials |
| NCT02507076 | Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma | withdrawn | N/A | 0 | Albert Einstein College of MedicineOTHER | 1 | Jul 23, 2015 | clinicaltrials |
| NCT01480323 |
| A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2 |
| completed |
| Phase 2 |
| 15 |
| University Hospital TuebingenOTHER |
| 1 |
| Jul 21, 2015 |
| clinicaltrials |
| NCT00518050 | Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns | completed | — | 160 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 16, 2015 | clinicaltrials |
| NCT02498756 | Cytokine-induced Killer Study for Patients With Stage II Melanoma | not yet recruiting | Phase 2 | 300 | The First People's Hospital of ChangzhouOTHER | 0 | Jul 15, 2015 | clinicaltrials |
| NCT01672450 | A Study of Intratumoral Injection of Interleukin-2 and Ipilimumab in Patients With Unresectable Stages III-IV Melanoma | completed | Phase 1 | 12 | University of UtahOTHER | 1 | Jul 8, 2015 | clinicaltrials |
| NCT02050594 | Ipilimumab 12-month Intensive Pharmacovigilance Protocol | completed | — | 6 | Bristol-Myers SquibbINDUSTRY | 1 | Jul 7, 2015 | clinicaltrials |
| NCT00996827 | Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma | terminated | — | 100 | New Mexico Cancer Research AllianceOTHER | 1 | Jun 18, 2015 | clinicaltrials |
| NCT00855452 | Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors(rIL-2(LAK)) | completed | Phase 2 | 20 | Hadassah Medical OrganizationOTHER | 1 | Jun 11, 2015 | clinicaltrials |
| NCT01681212 | Phase 2 Study of Ipilimumab Plus Dacarbazine in Japanese Patients With Advanced Melanoma | completed | Phase 2 | 21 | Bristol-Myers SquibbINDUSTRY | 1 | Jun 11, 2015 | clinicaltrials |
| NCT00022464 | CCI-779 in Treating Patients With Metastatic Melanoma | completed | Phase 2 | — | City of Hope Medical CenterOTHER | 2 | Jun 8, 2015 | clinicaltrials |
| NCT00110994 | Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma | completed | Phase 2 | 101 | BayerINDUSTRY | 1 | Jun 8, 2015 | clinicaltrials |
| NCT00776945 | Feasibility and Functionality of fPAM Imaging in Melanoma(fPAM) | terminated | — | 2 | Washington University School of MedicineOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT01085396 | Use of Fiber-optic Probe for Non-invasive Diagnosis of Melanoma and Assessment of Impact of Ultraviolet (UV) Exposure on Skin | terminated | — | 16 | University of PittsburghOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT02076633 | Intratumoral Administration of L19IL2/L19TNF | completed | Phase 2 | 21 | Philogen S.p.A.INDUSTRY | 1 | May 27, 2015 | clinicaltrials |
| NCT01216436 | Local Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic Melanoma | terminated | Phase 1 | 2 | Duke UniversityOTHER | 1 | May 25, 2015 | clinicaltrials |
| NCT02442466 | Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma | terminated | Early Phase 1 | 5 | MelCure SAINDUSTRY | 0 | May 20, 2015 | clinicaltrials |
| NCT01654692 | A Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic Melanoma(NIBIT-M1) | completed | Phase 2 | 86 | Italian Network for Tumor BiotherapyOTHER | 1 | May 13, 2015 | clinicaltrials |
| NCT00053391 | Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 1 / Phase 2 | 62 | University Hospital ErlangenOTHER | 1 | May 12, 2015 | clinicaltrials |
| NCT00074230 | Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma | completed | Phase 1 / Phase 2 | 82 | University Hospital ErlangenOTHER | 1 | May 12, 2015 | clinicaltrials |
| NCT00453050 | Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin | completed | Phase 1 | 11 | University of OklahomaOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT00885534 | Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic Melanoma | completed | Phase 2 | 7 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT01433302 | Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass | completed | — | 21 | M.D. Anderson Cancer CenterOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT01526486 | Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer | completed | N/A | 29 | Emory UniversityOTHER | 1 | May 6, 2015 | clinicaltrials |
| NCT01960634 | Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma(BRAFV600) | completed | — | 58 | Grupo Español Multidisciplinar de MelanomaOTHER | 1 | May 5, 2015 | clinicaltrials |
| NCT01960829 | Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study | unknown | Phase 2 | 60 | Peking University Cancer Hospital & InstituteOTHER | 1 | May 1, 2015 | clinicaltrials |
| NCT00020540 | Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00091338 | Interleukin-7 and Vaccine Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00005057 | Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma | completed | Phase 1 | — | National Human Genome Research Institute (NHGRI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00019175 | Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic Melanoma | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00482105 | Early Diagnosis of Melanoma Using Expression Profiling and Non-Invasive Sampling of Skin Cells(DermTech) | terminated | N/A | 7 | University of California, DavisOTHER | 1 | Apr 22, 2015 | clinicaltrials |
| NCT00826995 | Comparison of Video-Based Versus Written Patient Education on Melanoma | completed | N/A | 78 | University of California, DavisOTHER | 1 | Apr 22, 2015 | clinicaltrials |
| NCT00279058 | The Role of Peptide-loaded Dendritic Cells to Augment the Therapeutic Effect of Interleukin-2 | completed | Phase 1 / Phase 2 | 24 | Hadassah Medical OrganizationOTHER | 1 | Apr 21, 2015 | clinicaltrials |
| NCT01770002 | Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved? | completed | N/A | 50 | University of California, DavisOTHER | 1 | Apr 16, 2015 | clinicaltrials |
| NCT00089063 | Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT01851408 | Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 0 | Apr 15, 2015 | clinicaltrials |
| NCT00276835 | Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer | completed | Early Phase 1 | 15 | Northwestern UniversityOTHER | 1 | Apr 10, 2015 | clinicaltrials |
| NCT00984464 | Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma | completed | Phase 2 | 14 | Oncolytics BiotechINDUSTRY | 1 | Apr 10, 2015 | clinicaltrials |
| NCT01924923 | New Biopsy Technique for Uveal Melanoma | completed | — | 1 | Greater Houston Retina ResearchOTHER | 1 | Mar 26, 2015 | clinicaltrials |
| NCT00006237 | S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma | completed | Phase 3 | 432 | SWOG Cancer Research NetworkNETWORK | 2 | Mar 25, 2015 | clinicaltrials |
| NCT00029900 | ADI-PEG in Patients With Metastatic Melanoma | completed | Phase 1 | 15 | FDA Office of Orphan Products DevelopmentFED | 1 | Mar 25, 2015 | clinicaltrials |
| NCT00668512 | Intratumoral Injection Of Alpha-Gal Glycosphingolipids | completed | Phase 1 | 12 | University of Massachusetts, WorcesterOTHER | 1 | Mar 19, 2015 | clinicaltrials |
| NCT00753415 | A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) | completed | Phase 1 | 37 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Mar 17, 2015 | clinicaltrials |
| NCT00661336 | A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant Melanoma | withdrawn | Phase 1 | 0 | Duke UniversityOTHER | 1 | Mar 13, 2015 | clinicaltrials |
| NCT01127594 | Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity Melanoma by Isolated Limb Infusion | completed | Phase 1 | 29 | Douglas TylerOTHER | 1 | Mar 9, 2015 | clinicaltrials |
| NCT01752257 | EF5 in Melanoma Patients | completed | Phase 1 | 15 | Douglas TylerOTHER | 1 | Mar 9, 2015 | clinicaltrials |
| NCT00565968 | Sorafenib and Isolated Limb Infusion of Melphalan in Treating Patients With Stage III Melanoma of the Arm or Leg | completed | Phase 1 | 20 | Duke UniversityOTHER | 1 | Mar 6, 2015 | clinicaltrials |
| NCT00068211 | Study of ILX651 in Patients With Inoperable Locally Advanced or Metastatic Melanoma | completed | Phase 2 | — | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Mar 5, 2015 | clinicaltrials |
| NCT00072189 | A Phase II Study of UCN-01 in Metastatic Melanoma | terminated | Phase 2 | 17 | National Cancer Institute (NCI)NIH | 1 | Mar 2, 2015 | clinicaltrials |
| NCT02372708 | Clinical Research on the Treatments on Advanced Malignant Melanoma by Combining in Situ Immunotherapy and Laser Therapy | completed | — | 72 | Chinese PLA General HospitalOTHER | 1 | Feb 26, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Jul 27, 2015source: clinicaltrials